Blue Man: Melaninophagia Secondary to Imatinib (2017)
Source: Journal of Pharmacological Reports. Unidade: FMRP
Subjects: NEOPLASIAS GASTROINTESTINAIS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANDIDO, P. B. M. et al. Blue Man: Melaninophagia Secondary to Imatinib. Journal of Pharmacological Reports, v. 2, n. 1, p. 3 , 2017Tradução . . Disponível em: https://www.omicsonline.org/open-access/blue-man-melaninophagia-secondary-to-imatinib.pdf. Acesso em: 04 out. 2024.APA
Candido, P. B. M., Anjos, C. S. D., Rosa, V. D. L., Rapatoni, L., Peria, F. M., & Fischer, I. R. (2017). Blue Man: Melaninophagia Secondary to Imatinib. Journal of Pharmacological Reports, 2( 1), 3 . Recuperado de https://www.omicsonline.org/open-access/blue-man-melaninophagia-secondary-to-imatinib.pdfNLM
Candido PBM, Anjos CSD, Rosa VDL, Rapatoni L, Peria FM, Fischer IR. Blue Man: Melaninophagia Secondary to Imatinib [Internet]. Journal of Pharmacological Reports. 2017 ; 2( 1): 3 .[citado 2024 out. 04 ] Available from: https://www.omicsonline.org/open-access/blue-man-melaninophagia-secondary-to-imatinib.pdfVancouver
Candido PBM, Anjos CSD, Rosa VDL, Rapatoni L, Peria FM, Fischer IR. Blue Man: Melaninophagia Secondary to Imatinib [Internet]. Journal of Pharmacological Reports. 2017 ; 2( 1): 3 .[citado 2024 out. 04 ] Available from: https://www.omicsonline.org/open-access/blue-man-melaninophagia-secondary-to-imatinib.pdf
